As many as one in three women treated for breast cancer undergo unnecessary procedures, but a new method for diagnosing it could do a better job distinguishing between benign and aggressive tumors.
Researchers at the University of Michigan are developing a pill that makes tumors light up when exposed to infrared light, and they have demonstrated that the concept works in mice.
Mammography is an imprecise tool. About a third of breast cancer patients treated with surgery or chemotherapy have tumors that are benign or so slow-growing that they would never have become life-threatening, according to a study out of Denmark last year. In other women, dense breast tissue hides the presence of lumps and results in deaths from treatable cancers. All that, and mammograms are notoriously uncomfortable.
“We overspend $4 billion per year on the diagnosis and treatment of cancers that women would never die from,” said Greg Thurber, U-M assistant professor of chemical engineering and biomedical engineering, who led the team. “If we go to molecular imaging, we can see which tumors need to be treated.”
The move could also catch cancers that would have gone undetected. Thurber’s team uses a dye that responds to infrared light to tag a molecule commonly found on tumor cells, in the blood vessels that feed tumors and in inflamed tissue. By providing specific information on the types of molecules on the surface of the tumor cells, physicians can better distinguish a malignant cancer from a benign tumor.
Compared to visible light, infrared light penetrates the body easily—it can get to all depths of the breast without an X-ray’s tiny risk of disrupting DNA and seeding a new tumor. Using a dye delivered orally rather than directly into a vein also improves the safety of screening, as a few patients in 10,000 can have severe reactions to intravenous dyes. These small risks turn out to be significant when tens of millions of women are screened every year in the U.S. alone.
But it’s not easy to design a pill that can carry the dye to the tumor.
“To get a molecule absorbed into the bloodstream, it needs to be small and greasy. But an imaging agent needs to be larger and water-soluble. So you need exact opposite properties,” Thurber said.
Fortunately, they weren’t the only people looking for a molecule that could get from the digestive system to a tumor. The pharmaceutical company Merck was working on a new treatment for cancer and related diseases. They got as far as phase II clinical trials demonstrating its safety, but unfortunately, it wasn’t effective.
“It’s actually based on a failed drug,” Thurber said. “It binds to the target, but it doesn’t do anything, which makes it perfect for imaging.”
The targeting molecule has already been shown to make it through the stomach unscathed, and the liver also gives it a pass, so it can travel through the bloodstream. The team attached a molecule that fluoresces when it is struck with infrared light to this drug. Then, they gave the drug to mice that had breast cancer, and they saw the tumors light up.
The research is described in a study in the journal Molecular Pharmaceutics, titled, “Oral administration and detection of a near-infrared molecular imaging agent in an orthotopic mouse model for breast cancer screening.”
The Latest on: Breast cancer diagnosis
via Google News
The Latest on: Breast cancer diagnosis
- October is Breast Cancer Awareness Month. This is one survivor’s storyon October 9, 2020 at 2:50 am
It was metastatic, invasive, ductal, in situ, breast cancer,” she said. “They also noticed the cancer had grown out of the duct and into a lymph node in my chest.” Hirschfield said the doctors also ...
- Casting for Recovery allow breast Erie cancer survivors to reel in fly fishing memorieson October 9, 2020 at 1:02 am
The Centers for Disease Control and Prevention estimates that nearly 270,000 Americans, including 2,600 males, are diagnosed annually with breast cancer. Roughly 42,000 of those diagnosed die from its ...
- Americans skipping cancer screenings is raising concern ahead of Breast Cancer Awareness Monthon October 9, 2020 at 12:47 am
According to BreastCancer.org "during the pandemic, the weekly average number of people diagnosed with these six cancers dropped by 46.4 percent. Specifically, breast cancer diagnoses dropped by 51.8 ...
- Mother diagnosed with breast cancer puts out desperate call for generator ahead of stormon October 8, 2020 at 6:50 pm
BATON ROUGE, La. (WAFB) - During the pandemic and hurricane season, Kathleen Fritchie and her daughter, Annelise Fritchie, keep trying to push forward. Kathleen was diagnosed with breast cancer, and ...
- Local breast cancer survivor offers warning after diagnosis in her twentieson October 8, 2020 at 3:25 pm
Randall now has a 6-month-old baby boy named, Levi. She also works with the "HER" program at the James Graham Brown Cancer Center which is for patients 45 and younger who are diagnosed with breast ...
- TAO Chicago partner shares dedication to Real Men Wear Pink during Breast Cancer Awareness Monthon October 8, 2020 at 11:33 am
Gewanter joined ABC 7 Chicago Thursday to talk about his mother, who continues to battle breast cancer. His male cousin was also diagnosed with breast cancer, but is doing fine. "I try to help ...
- Trans woman urges to be 'proactive' after rare breast cancer diagnosison October 7, 2020 at 6:23 am
When she learned she had cancer, Beverly Lipscomb worried how the doctors would treat her because she is transgender.
- Identical twins in NJ share identical breast cancer diagnosison October 6, 2020 at 6:01 pm
Identical twins are the result of a single egg that splits, so they share the same DNA and are helping researchers answer questions about genetics and breast cancer.
- Olivia Newton-John tearfully talks breast cancer diagnosis: ‘I knew immediately something was wrong’on October 6, 2020 at 10:48 am
John opened up about the first time she was diagnosed with breast cancer in a tearful video shared on Monday. The “ A Little More Love ” singer was first diagnosed with the disease in 1992, had a ...
via Bing News